How do Tablet Dissolution Testers work?
A dissolution tester places the dosage form in a vessel of temperature-controlled medium, usually 500–1000 mL of buffer or acid, and agitates it by a rotating basket (Apparatus 1), paddle (Apparatus 2), reciprocating cylinder (Apparatus 3) or flow of medium (Apparatus 4). Aliquots are withdrawn at specified times through filters and assayed by UV-Vis or HPLC. The key components are a thermostatted water bath or waterless heater, a drive head holding shaft speed within ±2 rpm, polished glass or plastic vessels of defined geometry, and calibrated shafts with minimal wobble. Hydrodynamics, shaft position, centering and vibration all influence results, so mechanical qualification is integral. Drug release follows Noyes–Whitney kinetics, where dissolution rate depends on surface area, solubility and boundary layer thickness, and sink conditions must be maintained so that the medium volume is at least three times the saturation volume.
Which Tablet Dissolution Testers variants are available?
- Six-Vessel Basket/Paddle Dissolution Tester — A six-vessel dissolution tester runs USP Apparatus 1 (basket) and Apparatus 2 (paddle) on six 1 L vessels in a thermostatted water bath.
- Eight-Vessel Dissolution Tester — An eight-vessel dissolution tester extends the USP Apparatus 1/2 layout to eight stations, so a test batch plus reference standards or a blank can run in one cycle.
- Automated Dissolution Tester with Online UV Sampling — An automated dissolution tester with online UV sampling combines a USP Apparatus 1/2 bath with a peristaltic or syringe sampler and a fibre-optic or flow-cell UV detector.
- Reciprocating Cylinder Dissolution Tester (USP Apparatus 3) — A reciprocating cylinder dissolution tester operates USP Apparatus 3, dipping the dosage form in a glass tube with mesh ends up and down through a series of media.
- Transdermal Dissolution Tester (USP Apparatus 5/6) — A transdermal dissolution tester adapts a six-vessel bath to USP Apparatus 5 (paddle over disk) and Apparatus 6 (rotating cylinder) for patches and other transdermal delivery systems.
How do I choose the right variant?
Start with the apparatus type the monograph specifies: Apparatus 1 or 2 for most immediate-release products, Apparatus 3 for extended-release and pH-shift profiling, Apparatus 5 or 6 for patches. Then choose vessel count by throughput: six for routine QC, eight for batches with standards, and automated systems for unattended profiles. Consider temperature control (bath versus waterless), speed range and accuracy, and compatibility with an autosampler or UV interface. For regulated sites, require IQ/OQ documentation, mechanical calibration fixtures, and software with audit trail. Also check vessel volume range, because low-dose or poorly soluble products may need 100–250 mL mini-vessels or 2–4 L vessels.
Where are Tablet Dissolution Testers used?
Tablet Dissolution Testers are specified in pharmaceutical QC, generic drug bioequivalence support, formulation development, stability testing and transdermal product release testing.
Which standards and certifications apply?
Work with Tablet Dissolution Testers is commonly governed by USP <711>, USP <1092>, Ph. Eur. 2.9.3, JP 6.10, ChP 0931, USP <724>, ASTM E2503 and FDA Guidance on Dissolution Testing of Immediate Release Solid Oral Dosage Forms. Instrument certifications such as CE marking are confirmed per configuration and never assumed.
What are the key considerations before purchase?
Place the tester on a vibration-free bench, level it, and keep it away from air currents and centrifuges. Perform mechanical calibration of shaft wobble, vessel centering, verticality, speed and temperature at installation and at regular intervals, and run performance verification with USP prednisone or salicylic acid calibrator tablets. Degas media to prevent bubbles, clean vessels after each run, inspect shafts and baskets for corrosion or damage, and replace filters per SOP. Documentation should cover IQ/OQ/PQ, calibration records, and data-integrity controls.
